Cargando…
Estimation of Time Period for Effective Human Inhalational Anthrax Treatment Including Antitoxin Therapy
INTRODUCTION: Infrequent natural human inhalational anthrax cases coupled with high bioterrorism risk have brought about use of animal models to serve as the basis for approval of novel treatments. For inhalational anthrax, protective antigen (PA) drives much of the mortality, and raxibacumab, an an...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5555766/ https://www.ncbi.nlm.nih.gov/pubmed/28856066 http://dx.doi.org/10.1371/currents.outbreaks.7896c43f69838f17ce1c2c372e79d55d |